Trial Profile
Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Guanfacine (Primary)
- Indications Impulse control disorders
- Focus Therapeutic Use
- 05 Oct 2017 Status changed from recruiting to completed.
- 07 Feb 2014 New trial record